REG-ADDEX raises USD 2.8 million through its ATM agreement and extends cash runway to the fourth quarter 2027
Addex Therapeutics raised $2.8 million in gross proceeds through an At-the-Market offering agreement with H.C. Wainwright & Co., selling 437,869 ADSs. The transaction extends the company's cash runway into the fourth quarter of 2027, supporting the continued development of its neurological disorder portfolio.
Key figures
- Deal Value Usd
- 2800000
- Shares Offered
- 437869
- Runway
- Q4 2027
- Outstanding shares
- 210292217
- Underlying shares represented
- 52544280
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.